Combined Treatment Provides Benefit for Nasopharyngeal Cancer (02-22-2012)
Among patients with Stage II nasopharyngeal cancer (a type of head and neck cancer), adding chemotherapy to radiation therapy resulted in better survival than radiation therapy alone. These results were published in the Journal of the National Cancer... Continue Reading
Study Suggests B Vitamin and Omega-3 Fatty Acid Supplements Don’t Reduce Cancer Risk (02-21-2012)
Among people with a history of cardiovascular disease, taking dietary supplements of B vitamins and/or omega-3 fatty acids does not appear to reduce the risk of cancer. These results were published in the Archives of Internal Medicine.
Dietary supplements... Continue Reading
Study Suggests B Vitamin and Omega-3 Fatty Acid Supplements Don’t Reduce Cancer Risk (02-21-2012)
Among people with a history of cardiovascular disease, taking dietary supplements of B vitamins and/or omega-3 fatty acids does not appear to reduce the risk of cancer. These results were published in the Archives of Internal Medicine.
Dietary supplements... Continue Reading
Lynch Syndrome Also Linked with Breast and Pancreatic Cancer (02-17-2012)
A study of families with Lynch Syndrome has expanded the list of cancers related to the condition: carriers of a Lynch Syndrome gene mutation also appear to have an increased risk of breast cancer and pancreatic cancer. These results were published in... Continue Reading
Combination of Campath and Fludarabine Provides Benefit in CLL (02-16-2012)
Among people with previously treated, relapsed or refractory chronic lymphocytic leukemia (CLL), treatment with a combination of Campath® (alemtuzumab) and fludarabine results in better outcomes than treatment with fludarabine alone. These results were... Continue Reading
Aggressive Rectal Cancer More Common in Young Adults (02-15-2012)
Signet cell rectal cancer—an aggressive type of rectal cancer—is almost five times more common in patients under the age of 40 than in older patients.
These results were presented at the 97th Annual Clinical Congress of theAmericanCollege of Surgeons.
The... Continue Reading
Juvenile Arthritis Linked with Higher Cancer Risk (02-14-2012)
Children with juvenile idiopathic arthritis (JIA) have a higher risk of cancer than children without JIA. The increased risk does not appear to be due to arthritis medications, but additional research is warranted. These results were published in Arthritis... Continue Reading
Chemotherapy Alone Effective for Hodgkin’s Lymphoma (02-10-2012)
Among patients with Stage IA or IIA nonbulky Hodgkin’s lymphoma, treatment with chemotherapy alone resulted in better overall survival than treatment that included radiation therapy. These results were published in the New England Journal of Medicine.
Hodgkin’s... Continue Reading
Older Postmenopausal Women More Likely to Die From Breast Cancer (02-10-2012)
Among postmenopausal women with hormone receptor-positive breast cancer, the likelihood of dying from breast cancer increases with age. These results were published in the Journal of the American Medical Association.
Of the more than 200,000 cases of... Continue Reading
Breast Cancer Outcomes Vary By Age Among Postmenopausal Women (02-10-2012)
Among postmenopausal women with hormone receptor-positive breast cancer, the likelihood of dying from breast cancer increases with age. These results were published in the Journal of the American Medical Association.
Of the more than 200,000 cases of... Continue Reading
Many Doctors Report Screening for Ovarian Cancer (02-9-2012)
Despite evidence to the contrary, one in three US physicians who offer primary care to women believe that ovarian cancer screening is effective. These results were published in the Annals of Internal Medicine.
Roughly 70% of ovarian cancers are diagnosed... Continue Reading
Aromasin Provides Breast Benefit But Takes a Toll on Bone (02-8-2012)
Among healthy postmenopausal women at increased risk of breast cancer, the aromatase inhibitor Aromasin® (exemestane) reduces the risk of breast cancer but also increases bone loss. These results were published in Lancet Oncology.
Drugs that block the... Continue Reading